SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-003871
Filing Date
2020-11-12
Accepted
2020-11-12 17:15:25
Documents
54
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_10q-093020.htm 10-Q 472423
2 CERTIFICATION xenetic_ex3101.htm EX-31.1 9864
3 CERTIFICATION xenetic_ex3102.htm EX-31.2 9667
4 CERTIFICATION xenetic_ex3201.htm EX-32.1 4823
  Complete submission text file 0001683168-20-003871.txt   2278258

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20200930.xml EX-101.INS 278489
6 XBRL SCHEMA FILE xbio-20200930.xsd EX-101.SCH 31767
7 XBRL CALCULATION FILE xbio-20200930_cal.xml EX-101.CAL 39699
8 XBRL DEFINITION FILE xbio-20200930_def.xml EX-101.DEF 108188
9 XBRL LABEL FILE xbio-20200930_lab.xml EX-101.LAB 225990
10 XBRL PRESENTATION FILE xbio-20200930_pre.xml EX-101.PRE 172676
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 201307989
SIC: 2834 Pharmaceutical Preparations